cbdMD, Inc.
YCBD- Exchange
- NYSE
- Industry
- Perfumes, Cosmetics & Other Toilet Preparations
- SEC CIK
- 0001644903
No open-market purchases or sales by cbdMD, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $611.7K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by cbdMD, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for cbdMD, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sellers Bakari T. | Director | 4,324 | Apr 16, 2026 | 1 |
| Raines William F III | Director | 13,676 | Apr 16, 2026 | 1 |
| Stephen Scott G. | Director | 4,412 | Apr 16, 2026 | 1 |
| Swift Sibyl Nichole | Director | 4,145 | Apr 16, 2026 | 1 |
| Roe Kevin Charles | Director | 26,707 | Apr 16, 2026 | 1 |
| Porter Jeffrey H | Director | 3,144 | Apr 16, 2026 | 1 |
| Crosnoe Clark R. | 10% Owner | 17,875Indirect | Dec 19, 2025 | 1 |
| Kennedy Thomas Ronan | CEO and CFO | 513,722 | Dec 2, 2025 | 1 |
| Coffman Raymond Scott | 10% Owner | 387,695Indirect | Jan 18, 2024 | 0 |
| Sumichrast Martin A. | Chairman, CEO | 1,894,533Indirect | May 19, 2022 | 0 |
| MacDermott Kevin | President | 126,000 | May 18, 2022 | 0 |
| Ghiloni Peter J. | Director | 310,000 | Apr 19, 2022 | 0 |
| Farar Sim | Director | 7,000 | Oct 5, 2021 | 0 |
| Wiesehan John J III | Chief Revenue Officer | 176,450 | Sep 29, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 (view filing) | Dec 17 | 2 days | Crosnoe Clark R.10% Owner | SSale | −550.7K | $2.31 | −$1.27M | −96.9%17.9K after | 3 lots |
| Sep 30, 2024 (view filing) | Sep 26 | 4 days | Kennedy Thomas RonanCEO and CFO | PPurchase | +4 | $137.50 | +$550 | –41.8K after | Derivative |
| Sep 25, 2024 (view filing) | Sep 23 | 2 days | Kennedy Thomas RonanCEO and CFO | PPurchase | +143 | $161.39 | +$23.1K | –40.8K after | Derivative |
| May 5, 2023 (view filing) | May 3 | 2 days | Kennedy Thomas RonanInterim CEO and CFO | PPurchase | −5.00K | $2.10 | −$10.5K | −43.6%6.46K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Kennedy Thomas RonanCFO & COO | PPurchase | +7.40K | $2.04 | +$15.1K | New position7.40K after | |
| Aug 25, 2021 (view filing) | Aug 24 | 1 day | Kennedy Thomas RonanCFO & COO | PPurchase | +3.83K | $3.91 | +$15.0K | –2.30K after | Derivative |
| Aug 20, 2021 (view filing) | Aug 18 | 2 days | Wiesehan John J IIIChief Revenue Officer | PPurchase | +3.33K | $4.18 | +$13.9K | –2.00K after | Derivative |
| Jul 26, 2021 (view filing) | Jul 22 | 4 days | Wiesehan John J IIIChief Revenue Officer | PPurchase | +161.6K | – | – | New position161.6K after |